Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
Near Add Your Location
Accepting patients
211At-BC8-B10
A Phase I/II Study Evaluating Escalating Doses of 211At-Labeled Anti-CD45 MAb BC8-B10 (211At-BC8-B10) Followed by Related Haplo-Identical Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Allogeneic Stem Cell Transplant
- Monoclonal Antibody
- Phase 1/2
Showing 1-1 of 1